4378-55-6

Basic information

• Product Name: 5-(3,4-DIMETHOXYPHENYL)-5-OXOVALERIC ACID
• Synonyms: 5-(3,4-DIMETHOXYPHENYL)-5-OXOVALERIC ACID;OTAVA-BB 1043544
• CAS NO: 4378-55-6
• Molecular Formula: C₁₃H₁₆O₅
• Molecular Weight: 252.26
• Mol File: 4378-55-6.mol
• Article Data: 10

Chemical Properties

• Melting Point: 145-146°C
• Boiling Point: 451.8°C at 760 mmHg
• Flash Point: 172.1°C
• Appearance: /
• Density: 1.183g/cm³
• Vapor Pressure: 5.94E-09mmHg at 25°C
• Refractive Index: 1.522
• CAS DataBase Reference: 5-(3,4-DIMETHOXYPHENYL)-5-OXOVALERIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3,4-DIMETHOXYPHENYL)-5-OXOVALERIC ACID(4378-55-6)
• EPA Substance Registry System: 5-(3,4-DIMETHOXYPHENYL)-5-OXOVALERIC ACID(4378-55-6)

Safety Data

• Hazardous Substances Data: 4378-55-6(Hazardous Substances Data)

Usage

General Description

5-(3,4-Dimethoxyphenyl)-5-oxovaleric acid is a chemical compound with the molecular formula C13H16O6. It is a derivative of valeric acid and contains a five-carbon chain with a ketone group and a phenyl ring with two methoxy groups. 5-(3,4-DIMETHOXYPHENYL)-5-OXOVALERIC ACID is commonly used as a building block in organic synthesis and pharmaceutical research. It has potential applications in the development of new drugs and bioactive molecules due to its structural characteristics. Additionally, it may have industrial uses as a precursor in the production of various chemical compounds. Overall, 5-(3,4-Dimethoxyphenyl)-5-oxovaleric acid is an important intermediate compound with diverse potential applications in various fields.

InChI:InChI=1/C13H16O5/c1-17-11-7-6-9(8-12(11)18-2)10(14)4-3-5-13(15)16/h6-8H,3-5H2,1-2H3,(H,15,16)

Upstream product

• 108-55-4 glutaric anhydride, 
• 91-16-7 1,2-dimethoxybenzene 
• 101499-71-2 5-(3,4-dimethoxy-phenyl)-5-oxo-valeric acid ethyl ester 
• 1070-62-8 5-ethoxy-5-oxopentanoic acid 
• 53715-97-2 5,5'-oxybis(5-oxopentanoic acid) 

Downstream Products

• 1145-15-9 5-(3,4-dimethoxyphenyl)pentanoic acid 
• 101499-71-2 5-(3,4-dimethoxy-phenyl)-5-oxo-valeric acid ethyl ester 
• 79623-03-3 5-hydroxy-5-(3,4-dimethoxyphenyl)valeric acid δ lactone 
• 131699-22-4 5-(3,4-dimethoxy-phenyl)-5-oxo-pentanoic acid methyl ester 
• 874518-45-3 5-(3,4-dimethoxyphenyl)pentanoic acid ethyl ester 
• 220396-75-8 2-(4-carboxybutyl)-4,5-dimethoxybenzenesulfonamide 
• 220396-70-3 2-(4-ethoxycarbonylbutyl)-4,5-dimethoxybenzenesulfonyl chloride 
• 220396-72-5 2-(4-ethoxycarbonylbutyl)-4,5-dimethoxybenzenesulfonamide 
• 1609188-55-7 2,3-dimethoxy-5-(2-methoxyphenyl)-8,9-dihydro-7H-benzocycloheptene-6-carbaldehyde 
• 1609188-58-0 2,3-dimethoxy-5-(2-methoxyphenyl)-8,9-dihydro-7H-benzocycloheptene-6-carboxylic acid 

Relevant articles and documents

Design and synthesis of 4,5,6,7‐tetrahydro‐1H‐1,2‐diazepin‐7‐one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors

Phosphodiesterase 4 (PDE4) inhibitors have attractive therapeutic potential in respiratory, inflammatory, metabolic and CNS disorders. The present work details the design, chemical exploration and biological profile of a novel PDE4 inhibitor chemotype. A

Iridium/f-Amphol-catalyzed Efficient Asymmetric Hydrogenation of Benzo-fused Cyclic Ketones

Iridium/f-Amphol-catalyzed asymmetric hydrogenation of various benzo-fused five to seven-membered cyclic ketones was successfully developed, affording a series of chiral benzo-fused cyclic alcohols with excellent results (75%–99% yields, 93%–>99% ee, and TON up to 297 000). The enantioenriched products can be employed as key intermediates or motifs for the synthesis of some important biologically active compounds, such as rasagiline mesylate TVP-1012 used for the treatment of Parkinson's disease, the enantiomer of anticonvulsant drug eslicarbazepine acetate (BIA 2-093). (Figure presented.).

Increasing the open circuit voltage of bulk-heterojunction solar cells by raising the LUMO level of the acceptor

We report the synthesis, characterization, and electrochemical properties of ten new fullerene derivatives for usage in organic solar cells. The phenyl ring of PCBM was substituted with electron-donating and electron-withdrawing substituents to study thei